Page 2 - Raf And Mek Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

New Clinical Trial Opening for People with Rare Ovarian Cancer

New Clinical Trial Opening for People with Rare Ovarian Cancer
wcvb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wcvb.com Daily Mail and Mail on Sunday newspapers.

United statesConnie bellRaf and mek program

Verastem Oncology Announces Multiple Oral Presentations at SGO 2024 Annual Meeting on Women s Cancer that Highlight Advances in Low-Grade Serous Ovarian Cancer Research and Reinforce Commitment to Addressing Urgent Unmet Needs

Verastem Oncology Announces Multiple Oral Presentations at SGO 2024 Annual Meeting on Women s Cancer that Highlight Advances in Low-Grade Serous Ovarian Cancer Research and Reinforce Commitment to Addressing Urgent Unmet Needs
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesMichelle greenmanRacheln grishamSusanna banerjeeDan patersonCharlottec sunPatient impactCompany annual report on formGrade serous ovarian cancer researchExchange commissionRaf and mek programChugai pharmaceutical co ltdSecura bio incGenfleet therapeutics shanghai incSociety of gynecologic oncology

Verastem Oncology Announces Multiple Oral Presentations at SGO 2024 Annual Meeting on Women s Cancer that Highlight Advances in Low-Grade Serous Ovarian Cancer Research and Reinforce Commitment to Addressing Urgent Unmet Needs -March 11, 2024 at 07:31 am EDT

Late-breaking oral presentation of a subgroup analysis in RAMP 201 Part A heavily pretreated patients receiving avutometinib and defactinib and their best response compared to most recent prior.

San diegoUnited statesMichelle greenmanRacheln grishamDan patersonCharlottec sunSusanna banerjeeExchange commissionDrug administrationPatient impactGenfleet therapeutics shanghai incRaf and mek programChugai pharmaceutical co ltdSociety of gynecologic oncologySecura bio incCompany annual report on form

Verastem Oncology Granted Fast Track Designation for Combination of Avutometinib and Sotorasib for the Treatment of KRAS G12C-Mutant Non-Small Cell Lung Cancer (NSCLC)

Verastem Oncology Granted Fast Track Designation for Combination of Avutometinib and Sotorasib for the Treatment of KRAS G12C-Mutant Non-Small Cell Lung Cancer (NSCLC)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Dan patersonRyan porterElisa buffingtonRaf and mek programInternational conference on molecularSecura bio incCorporate communicationsExchange commissionCompany annual report on formDrug administrationChugai pharmaceutical co ltdMore complete vertical blockadeImprove outcomesResponses observedPre treated patientsEnrollment ongoing

Verastem Oncology Selects Oral KRAS G12D Inhibitor GFH375/VS-7375 as Lead Program in Discovery and Development Collaboration with GenFleet Therapeutics

Investigational New Drug Submission Planned for GFH375/VS-7375 in H1 2024 No FDA Approved Therapies Available Targeting KRAS G12D, the Most Prevalent KRAS Mutation in Human Cancer .

Dan patersonExchange commissionDrug administrationCompany annual report on formChugai pharmaceutical co ltdRaf and mek programSecura bio incVerastem oncologyGenfleet therapeuticsChief executive officerBreakthrough therapySecura bioAnnual report